These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 28864046)
21. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Corvò R Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300 [TBL] [Abstract][Full Text] [Related]
22. Postoperative radiotherapy for squamous cell carcinoma of the head and neck. Mendenhall WM; Hinerman RW; Amdur RJ; Malyapa RS; Lansford CD; Werning JW; Villaret DB Clin Med Res; 2006 Sep; 4(3):200-8. PubMed ID: 16988100 [TBL] [Abstract][Full Text] [Related]
23. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status. Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650 [TBL] [Abstract][Full Text] [Related]
24. Chemotherapy of squamous cell carcinoma of head and neck: the future is now. Vokes EE; Athanasiadis I Ann Oncol; 1996 Jan; 7(1):15-29. PubMed ID: 9081382 [TBL] [Abstract][Full Text] [Related]
25. Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review. Bonomo P; Loi M; Desideri I; Olmetto E; Delli Paoli C; Terziani F; Greto D; Mangoni M; Scoccianti S; Simontacchi G; Francolini G; Meattini I; Caini S; Livi L Crit Rev Oncol Hematol; 2017 Dec; 120():98-110. PubMed ID: 29198343 [TBL] [Abstract][Full Text] [Related]
26. Chemotherapy for localized head and neck squamous cell cancers. Karabajakian A; Toussaint P; Neidhardt EM; Paulus V; Saintigny P; Fayette J Anticancer Drugs; 2017 Apr; 28(4):362-368. PubMed ID: 28134662 [TBL] [Abstract][Full Text] [Related]
27. Importance of Chemotherapy and Radiation Dose After Microscopically Incomplete Resection of Stage III/IV Head and Neck Cancer. Seidl D; Janssen S; Strojan P; Hakim SG; Wollenberg B; Schild SE; Rades D Anticancer Res; 2016 May; 36(5):2487-91. PubMed ID: 27127162 [TBL] [Abstract][Full Text] [Related]
28. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma. Dirix P; Nuyts S Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402 [TBL] [Abstract][Full Text] [Related]
29. A retrospective, multicenter study of the tolerance of induction chemotherapy with docetaxel, Cisplatin, and 5-Fluorouracil followed by radiotherapy with concomitant cetuximab in 46 cases of squamous cell carcinoma of the head and neck. Buiret G; Combe C; Favrel V; Pommier P; Martin L; Ecochard R; Fayette J; Tartas S; Ramade A; Céruse P Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):430-7. PubMed ID: 19775831 [TBL] [Abstract][Full Text] [Related]
30. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609 [TBL] [Abstract][Full Text] [Related]
31. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. Cooper JS; Pajak TF; Forastiere AA; Jacobs J; Campbell BH; Saxman SB; Kish JA; Kim HE; Cmelak AJ; Rotman M; Machtay M; Ensley JF; Chao KS; Schultz CJ; Lee N; Fu KK; N Engl J Med; 2004 May; 350(19):1937-44. PubMed ID: 15128893 [TBL] [Abstract][Full Text] [Related]
32. Current concepts of management in radiotherapy for head and neck squamous-cell cancer. Mazeron R; Tao Y; Lusinchi A; Bourhis J Oral Oncol; 2009; 45(4-5):402-8. PubMed ID: 19375379 [TBL] [Abstract][Full Text] [Related]
33. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options? Bourhis J; Lefebvre JL; Vermorken JB Eur J Cancer; 2010 Jul; 46(11):1979-89. PubMed ID: 20561781 [TBL] [Abstract][Full Text] [Related]
34. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update. Bernier J Curr Opin Oncol; 2008 May; 20(3):249-55. PubMed ID: 18391622 [TBL] [Abstract][Full Text] [Related]
35. Chemotherapy and combined modality therapy in head and neck cancer. Hamasaki VK; Vokes EE Curr Opin Oncol; 1993 May; 5(3):508-17. PubMed ID: 8494912 [TBL] [Abstract][Full Text] [Related]
36. New perspectives in medical approach to therapy of head and neck squamous cell carcinoma. Santarelli A; Lo Russo L; Bambini F; Campisi G; Lo Muzio L Minerva Stomatol; 2009 Sep; 58(9):445-52. PubMed ID: 19893469 [TBL] [Abstract][Full Text] [Related]
37. Current treatments and promising investigations in a multidisciplinary setting. Vokes E Ann Oncol; 2005; 16 Suppl 6():vi25-vi30. PubMed ID: 15987993 [TBL] [Abstract][Full Text] [Related]
38. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer. Duprez F; Bonte K; De Neve W; Boterberg T; De Gersem W; Madani I Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):450-8. PubMed ID: 20381266 [TBL] [Abstract][Full Text] [Related]
39. Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck. Villavicencio M; Granados-García M; Vilajosana E; Domínguez-Cherit J Int J Dermatol; 2017 Jun; 56(6):602-609. PubMed ID: 28247918 [TBL] [Abstract][Full Text] [Related]
40. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio? Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]